GENE ONLINE|News &
Opinion
Blog

2025-12-01|

Study Explores Link Between Prematurity, Neonatal Complications, and Hearing Function in Children of HIV-Positive Mothers in South Africa

by GOAI
Share To

A recent study has explored the connection between prematurity, neonatal complications, and hearing function in children born to HIV-positive mothers in South Africa. Researchers Khoza-Shangase and Mnyaka conducted the investigation to better understand how early-life health challenges may impact auditory development in this population. The study focuses on identifying potential risks and contributing factors that could affect hearing abilities in these children.

The research highlights the role of prematurity and neonatal health issues as significant factors influencing hearing outcomes. It examines how these conditions interact with maternal HIV status to potentially exacerbate auditory impairments. By focusing on a vulnerable group, the study provides insight into the complex interplay between early medical complications and long-term sensory development. The findings aim to inform healthcare strategies for improving outcomes for children born under similar circumstances.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top